Jasper Therapeutics Inc (JSPR) reports earnings on August 12. Lets take a closer look at how the stock is currently trading.
Shares of JSPR were trading at $2.03 as of August 04. Over the last 52-weeks, shares are down -89.25%. A larger percentage here can mean investors have a stronger bullish or bearish outlook on the stock.
Analysts are estimating Jasper Therapeutics Inc will report an EPS (earnings per share) of -$0.36. Over the last 90 days, analysts have lowered estimates once. The revision could belay some uncertainty or pessimism in the estimate.
Bulls will want to hear that the company beat the analysts' estimates and that the beat is on unexpectedly higher revenues. They'll also want the company to paint a picture that leads analysts to conclude this is just the start of an robust growth story that will play out in the following quarters.
When they're finished harrassing campers, chasing hikers, or Mauling Leonard DiCaprio in the Revenant, JSPR bears will be listening for news that the company underperformed the analysts' estimates. They'll also want to hear about a negative growth story that frames the company's future as one of deceleration or even decline in revenues over the following quarters.
If you haven't traded too many earnings reports, it's important to be aware that a stock's price movement can be caused by a change in the analysts' estimates based on the Q&A from the conference call with management discussing the earnings report. As you see more of these reports, your ability to recognize changes in investor sentiment will improve.